Nitrofurantoin mono mcr 100 refers to a specific formulation of nitrofurantoin, an antibiotic used to treat urinary tract infections (UTIs). The "mono mcr" likely indicates a monohydrate crystalline form, and "100" typically refers to the milligram (mg) strength of the capsule. This formulation is designed for controlled-release properties.
How does nitrofurantoin work for UTIs?
Nitrofurantoin works by being reduced by bacterial enzymes to intermediates that damage bacterial ribosomal proteins, DNA, and RNA. This process inhibits the growth and reproduction of various bacteria commonly responsible for UTIs, such as Escherichia coli. The drug is particularly effective in the urine because it achieves high concentrations there [1].
What are the advantages of this controlled-release formulation?
Controlled-release formulations, like nitrofurantoin mono mcr 100, aim to provide a more consistent drug level in the body over a longer period. This can potentially lead to better patient adherence and a reduced risk of fluctuating drug concentrations, which might contribute to treatment effectiveness and potentially fewer side effects associated with rapid absorption or elimination.
When is nitrofurantoin mono mcr 100 prescribed?
Nitrofurantoin mono mcr 100 is typically prescribed for the treatment of acute uncomplicated urinary tract infections in adults and children [1]. It is also sometimes used for the prevention (prophylaxis) of recurrent UTIs in certain individuals.
What are the common side effects of nitrofurantoin?
Common side effects associated with nitrofurantoin can include nausea, vomiting, headache, and dizziness. Less common but more serious side effects can involve pulmonary reactions, liver toxicity, and peripheral neuropathy. Patients with certain pre-existing conditions, such as kidney impairment, may have a higher risk of experiencing adverse effects [1].
Are there any contraindications for nitrofurantoin?
Nitrofurantoin is contraindicated in patients with a history of hypersensitivity to the drug, severe renal impairment, and in the last trimester of pregnancy. It is also generally avoided in infants under one month of age due to the risk of hemolytic anemia [1].
What is the typical dosage for nitrofurantoin mono mcr 100?
For treating UTIs, the typical dosage for nitrofurantoin mono mcr 100 is often one 100 mg capsule four times daily for uncomplicated UTIs. For prophylaxis, the dosage may be adjusted, commonly to one 100 mg capsule at bedtime [1].
How does nitrofurantoin compare to other UTI antibiotics?
Other antibiotics commonly used for UTIs include trimethoprim-sulfamethoxazole, fosfomycin, and fluoroquinolones. Nitrofurantoin is often a preferred first-line treatment for uncomplicated UTIs, especially when drug resistance to other agents is a concern. However, its use may be limited in cases of kidney impairment or severe infections. The choice of antibiotic depends on factors such as local resistance patterns, patient allergies, and individual health conditions [2].
What are the patent considerations for nitrofurantoin formulations?
Patents protect new drug formulations and manufacturing processes, granting exclusive rights to the patent holder for a specified period. The patent status of nitrofurantoin formulations, including controlled-release versions like mono mcr, can influence the availability and pricing of generic versions. DrugPatentWatch.com provides information on drug patents and exclusivity periods [3]. The expiry of patents allows for the introduction of generic competitors, which can lead to lower drug costs.
Sources:
1. Drug Information Resource
2. National Institute of Diabetes and Digestive and Kidney Diseases
3. DrugPatentWatch.com